Schedule of Warrant Activity (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2024
USD ($)
$ / shares
shares
| |
| Equity [Abstract] | |
| Number of Warrants, Outstanding | shares | 15,438,607 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 1.09 |
| Number of Warrants, Issued | shares | 5,415,696 |
| Weighted Average Exercise Price, Issued | $ / shares | $ 0.62 |
| Number of Warrants, Expired/Cacelled | shares | (85,000) |
| Weighted Average Exercise Price, Expired/Cancelled | $ / shares | $ 0.75 |
| Number of Warrants, Outstanding | shares | 20,769,303 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 0.97 |
| Weighted Average Remaining Life (In Years), Outstanding | 3 years 4 months 24 days |
| Intrinsic Value, Outstanding | $ | |
| Number of Warrants, Exercisable | shares | 20,769,303 |
| Weighted Average Exercise Price, Exercisable | $ / shares | $ 0.97 |
| Weighted Average Remaining Life (In Years), Exercisable | 3 years 4 months 24 days |
| Intrinsic Value, Exercisable | $ |
| X | ||||||||||
- Definition Number of warrant exercisable. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options expired weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrant. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non-options weighted average exercise price outstanding. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options exercisable intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangement by share-based payment award non-options exercisable weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by sharebased payment award non options outstanding weighted average remaining contractual term No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|